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Abstract
Background: As important regulators of developmental and adult processes in metazoans, Fibroblast Growth
Factor (FGF) proteins are potent signaling molecules whose activities must be tightly regulated. FGFs are known to
play diverse roles in many processes, including mesoderm induction, branching morphogenesis, organ formation,
wound healing and malignant transformation; yet much more remains to be learned about the mechanisms of
regulation used to control FGF activity.
Results: In this work, we conducted an analysis of the functional domains of two Drosophila proteins, Thisbe (Ths)
and Pyramus (Pyr), which share homology with the FGF8 subfamily of ligands in vertebrates. Ths and Pyr proteins
are secreted from Drosophila Schneider cells (S2) as smaller N-terminal fragments presumably as a result of
intracellular proteolytic cleavage. Cleaved forms of Ths and Pyr can be detected in embryonic extracts as well. The
FGF-domain is contained within the secreted ligand portion, and this domain alone is capable of functioning in
the embryo when ectopically expressed. Through targeted ectopic expression experiments in which we assay the
ability of full-length, truncated, and chimeric proteins to support cell differentiation, we find evidence that (1) the
C-terminal domain of Pyr is retained inside the cell and does not seem to be required for receptor activation and
(2) the C-terminal domain of Ths is secreted and, while also not required for receptor activation, this domain does
plays a role in limiting the activity of Ths when present.
Conclusions: We propose that differential protein processing may account for the previously observed inequalities
in signaling capabilities between Ths and Pyr. While the regulatory mechanisms are likely complex, studies such as
ours conducted in a tractable model system may be able to provide insights into how ligand processing regulates
growth factor activity.
Background
Fibroblast Growth Factors (FGFs) comprise a large
family of signalling molecules that are key regulators of
developmental processes including mesoderm induction,
gastrulation, cell migration, midbrain-hindbrain pattern-
ing, limb induction and bone formation [1-7]. FGFs con-
tinue to function in adult tissue homeostasis and wound
healing; when improperly activated they can also contri-
bute to many human diseases and cancer [7-10]. Most
of the 24 known FGF ligands in vertebrates are small
proteins with a molecular mass of 17-34 kD, whereas
the three known Drosophila FGF ligands are all pre-
dicted to be much larger proteins with molecular masses
of approximately 80 kD [11,12]. Vertebrate FGFs and
Drosophila FGFs share homology within their FGF
domains, but Drosophila FGFs have an additional long,
low-complexity sequence of unknown function.
The FGF ligands in Drosophila are Branchless (Bnl),
Thisbe (Ths), and Pyramus (Pyr), and they bind to FGF
receptors (FGFR), which are receptor tyrosine kinases
(RTKs). FGF signalling is used pervasively throughout
development. Bnl-mediated activation of the Breathless
(Btl) receptor controls branching of the developing tra-
chea [13], while Ths and Pyr activate the Heartless (Htl)
receptor to control movement of the mesoderm cells
[14-18], pericardial cell specification[15,16,18,19], and
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caudal visceral mesoderm migration [20,21]. Pyr and
Ths ligands also function later in development within
the nervous system to control glial cell proliferation,
migration and axonal wrapping [22]. Ths and Pyr are
thought to share one receptor, which makes Drosophila
an ideal model to study FGF signaling specificity and
differential regulation. Initial work on the individual
functions of Ths and Pyr in the embryo was recently
described using genetic approaches, where it was found
that although both ligands play a role in mesoderm
spreading, Pyr is more important for pericardial cell
specification [18,19].
In order to achieve a better understanding of how Ths
and Pyr proteins are adapted to their particular roles, it
is necessary to first understand the mechanism by which
signaling with a particular FGF ligand occurs, and the
way this signaling is regulated. Signaling ligands can be
intracellular, membrane-bound, or secreted, and are
often modified and processed in many different ways.
Understanding these basic properties of a signaling
ligand provides important clues for any further mechan-
istic studies.
Proteolytic processing is a common regulatory
mechanism of growth factors and other signaling path-
ways in both vertebrates and Drosophila. Examples from
Drosophila include the EGF ligand Spitz (Spi), TGF-b
ligands Decapentaplegic (Dpp) and Glass Bottom Boat
(Gbb), Spätzle, Notch, and Delta. Spi is cleaved in its
transmembrane domain to release a secreted form (sSpi)
that can bind to the Drosophila EGF Receptor (DER)
[23,24]. The Spätzle C-terminal cysteine knot is acti-
vated when cleaved away from an unstructured, inhibi-
tory N-terminal domain [25-27]. Dpp and Gbb, like
their vertebrate BMP homologs, are produced as inac-
tive preproproteins and cleaved by Furin1 and Furin2 to
release the mature, active protein [28]. Notch is pro-
duced as a single polypeptide but is then processed in
the secretory pathway by a furin-like protease within the
Golgi to produce two fragments that remain non-cova-
lently associated [29-31]. Lastly, Delta undergoes three
proteolytic cleavages and one of these cleavages is
dependent on the ADAM metalloprotease Kuzbanian
[32]. Uncovering the proteolytic processing events of
these growth factors and signaling molecules has led to
a deeper understanding of their signaling mechanism
and regulation.
Here we have found evidence for (1) the proteolytic
cleavage of Ths and Pyr full-length precursor proteins
and (2) the secretion of the FGF-domain-containing N-
terminus. The role of proteolytic processing in FGF sig-
naling is currently limited to one vertebrate FGF ligand,
FGF23, which is part of a subgroup of endocrine FGFs.
Full length FGF23 is 251 amino acids and is cleaved by
subtilisin-like proprotein convertases between amino
acids 179 and 180. In humans, failure of this cleavage
step results in secretion of additional full-length FGF23,
which can cause hypophosphatemia leading to autoso-
mal dominant hypophosphatemic rickets/osteomalacia
[33,34]. These studies support the view that a delicate
balance is necessary to control the level of secreted
bioactive FGF proteins [35]. We also show that after
processing, Ths and Pyr are similar in size to their ver-
tebrate homolog FGF8 (~G30 kD) suggesting that study-
ing regulation of FGF signaling in Drosophila could
provide useful insights for the FGF field in general.
In addition to understanding the processing of Ths
and Pyr, we sought to link the structural domains to the
function of the ligands. From embryonic stage 10 to 11,
the developing dorsal mesoderm requires activation of
the Htl receptor to specify two even-skipped (eve)
expressing progenitor cells, which give rise to three Eve-
positive founder cells [36]. Two of these Eve-positive
founders will become Eve-positive pericardial cells, and
the third founder will give rise to dorsal somatic muscle
[37-39]. When either Ths or Pyr are ectopically
expressed throughout the neurogenic ectoderm using a
69B-GAL4 driver, the Eve-positive cell cluster increases
from three cells to as many as 20 cells [16,18]. In this
work we used these supernumerary Eve-positive cells as
a functional readout of Ths and Pyr activity. By analyz-
ing a series of truncation, deletion, and chimeric con-
structs, our results collectively suggest that the N-
terminal FGF domain alone is sufficient to support func-
tion, but only when properly folded and secreted.
If the N-terminus alone is able to activate the receptor
and allow downstream signaling, then what is the role of
the long C-termini of Ths and Pyr? We addressed this
question with another GAL4 driver, ZenKr-GAL4,
which drives expression only in a subset of the dorsal
ectoderm of the early embryo (i.e., zenVRE.Kr-GAL4
[40]). Limiting the source of protein production to this
restricted domain allowed us to assay differences in the
range-of-action of different Ths and Pyr constructs. Our
results suggest that the Ths C-terminus is inhibitory
and the Pyr C-terminus is not. Collectively, these find-
ings demonstrate that post translational processing is
important for FGF signaling during embryonic develop-
ment of Drosophila and suggest that processing of sig-
naling ligands may be widespread.
Results
Comparison of predicted protein characteristics for
Thisbe and Pyramus
A screen to uncover genes involved in patterning the
dorsal-ventral axis of Drosophila, identified expression
of the thisbe gene (ths: previously called Neu4) in the
neurogenic ectoderm [41]. Results from additional
genetic experiments were consistent with the hypothesis
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that Ths and Pyr are two FGF ligands for the Htl FGF
receptor [15,16]. To understand the mechanism of FGF
signaling through Htl on a molecular level, we charac-
terized Ths and Pyr proteins by analysing their func-
tional domains. We first considered predictions about
the size and homologous domains of Ths and Pyr.
The ths cDNA contains a 2,247 basepair open-reading
frame and is predicted to encode a protein of 748
amino acids (aa) with a molecular weight of 82.2 kD.
Thisbe is predicted to have a N-terminal signal peptide
followed by a 122 aa FGF domain composed of 12 pre-
dicted b-strands separated by coiled-coil domains, which
presumably support a trefoil structure like vertebrate
FGFs. Beyond the FGF domain, however, the C-terminal
domain of Ths exhibits only limited homology within
deuterostomes, to other uncharacterized “immunoglobu-
lin-like proteins” or proteins that are known to be highly
glycosylated (data not shown). The Ths protein
sequence also contains several dibasic and multi-basic
motifs characteristic of the recognition site for furin
proteases [42,43] and several predicted N-linked glycosy-
lation sites (Fig. 1).
The pyr cDNA contains a 2,301 basepair open-reading
frame and is predicted to encode a protein of 766 aa
and ~87 kD. Pyr also has a N-terminal signal peptide
followed by a FGF domain of 128 aa (Fig. 1). Ths and
Pyr share 39% amino acid identity in the FGF core
domain. C-terminal to the Pyr FGF domain, there are
many repeats and regions of low complexity. From
amino acids 399 to 426, Pyr has a string of hydrophobic
amino acids that weakly qualifies as a potential
transmembrane domain when assayed by topology pre-
diction programs using the Kyte-Doolittle Scale [44].
Pyr also has sites of predicted N-linked and O-linked
glycosylation and putative dibasic and multi-basic pro-
tease recognition sites (see symbols in Fig. 1).
Ths and Pyr are secreted from S2 cells and detectable as
cleaved forms
To confirm the ability of the full-length ths and pyr
cDNAs to support the production of ~80 kD proteins as
predicted by their sequence, we expressed Ths and Pyr
proteins in vitro using a rabbit reticulocyte transcrip-
tion/translation kit that incorporates S35-labeled Methio-
nine. Full-length proteins were detected at ~80 kD, as
predicted (Fig. 2A).
We compared the size of Ths and Pyr proteins with
other ligands (e.g., Bnl, FGF8, Dpp, Spi, and FGF23; see
Fig. 1), and found Ths and Pyr to be much larger than
FGF8 and closer in size to other cleaved growth factors
in Drosophila like Dpp. Therefore, we hypothesized that
Ths and Pyr may also be regulated by cleavage. Dpp
(588aa) is activated by cleavage into much smaller mole-
cules consisting primarily of the TGFb-homologous
domain [28,45,46]. Spitz is an EGF ligand that, like Ths
and Pyr, uses a high-affinity RTK receptor to signal.
Spitz is cleaved within its transmembrane domain to
release the EGF domain as a small secreted ligand
[23,24]. All FGFs in vertebrates, even the cleaved
FGF23, are small molecules consisting mostly of the
FGF domain alone. These comparisons led us to con-
sider the hypothesis that Ths and Pyr may not signal as
Figure 1 Comparison of Ths and Pyr Proteins to other signalling ligands. thisbe and pyramus genes encode proteins of 748 and 766 amino
acids (aa), respectively, making them far larger than their vertebrate homolog FGF8, which is 204 aa. Branchless, another FGF ligand in
Drosophila, is also a relatively large protein of 770 aa. The C-terminus is cleaved from FGF23, the only FGF family member known to be cleaved
[33,34]. Dpp is produced as a 588 aa precursor, but is cleaved to primarily the TFG-b-homologous domain alone [23,28,45,46]. Spitz is processed
within its transmembrane domain and, like Thisbe and Pyramus, binds to a RTK receptor to signal [23,24]. Known cleavage sites are marked with
a black inverse triangle. In the Drosophila FGFs, potential cleavage sites consisting of multi-basic amino-acid motifs are marked with a white
inverse triangle. Predicted N-glycosylation sites are marked with an asterisk and predicted O-glycosylation sites are marked with a vertical line.
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Figure 2 FGFs are cleaved in S2 cell culture and embryonic extracts. (A) In vitro transcription/translation incorporating S35Met into Pyr (left)
and Ths (right) supports production of ~80 kD proteins, as predicted from the sequence. (B) Schematics of HA-Pyr-Myc and HA-Ths-Myc
constructs showing the position of the signal sequence (orange box), N-terminal HA-tag (blue box), FGF domain, and C-terminal Myc tag (green
box). Upon transfection of S2 cells, HA-Pyr-Myc and HA-Ths-Myc are secreted from cells as multiple bands around 50 kD for Pyr (lane 2) and 35
kD for Ths (lane 3), as detected by immunoprecipitation and immunoblot with anti-HA to track N-termini. Lane 1 and 4 are supernatant and cell
pellet controls transfected with empty vector (i.e., pUASt). Lane 5 and 6 are immunoprecipitations of HA-Pyr-Myc and HA-Ths-Myc from the cell
pellet, showing cleaved forms are already detectable inside the cell. (C) Extracts from wildtype embryos (yw) or embryos overexpressing HA-Ths
(Ths) or HA-Pyr (Pyr) with the 69B-GAL4 driver, immunoprecipitated with rat anti-HA and detected with mouse anti-HA reveal cleaved bands
around 35 kD for Ths and around 45 kD for Pyr. (D) (Left Blot) Supernatant (i.e., cell culture medium) from HA-Pyr-Myc and HA-Ths-Myc, without
immunoprecipitation, blotted with anti-HA antibody, shows a full-length band in the supernatant for Ths but not Pyr; the full-length Ths protein
is present at much lower levels than the cleaved form and is only observable upon longer exposure; for instance, in (B), lane 3, it is not
detected. (Right Blot) Immunoprecipitating with anti-Myc and blotting with anti-HA shows that the 150 kD band in Ths supernatant and cell
pellet has both the N- and C-terminus connected.
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long, full-length proteins, but as small molecules con-
sisting primarily of the FGF domain.
First, we sought to verify whether Ths and Pyr were
indeed secreted proteins by transiently expressing ths
and pyr from a metallothionine promoter in S2 cells, a
cell line derived from Drosophila embryonic cells. Dou-
ble mutants for ths and pyr genes (i.e. Def(2R)BSC25
[16]) phenocopy the htl mutant phenotype, but in the
early Drosophila embryo Ths and Pyr proteins are
expressed in the ectoderm while Htl is limited to the
abutting mesoderm cells. Thus, for Ths and Pyr to influ-
ence the activity of the Htl FGFR in the mesoderm, our
working hypothesis had been that the FGF ligands are
secreted from the ectoderm to activate the FGFR pre-
sent in the mesoderm. Consistent with this view, signal
sequences are predicted at the N-terminus within the
identified protein sequences [16]. Nevertheless, we
sought to examine secretion directly. In order to follow
both the N- and C-termini separately, we constructed
epitope-tagged constructs with a single hemagglutinin
(HA) tag at the N-terminus after the signal peptide and
a 6X Myc tag at the C-terminus (diagrams in Fig. 2B).
UASt.HA-Ths-Myc and UASt.HA-Pyr-Myc plasmids
were co-transfected into S2 cells along with the metal-
lothionine-inducible Gal4 plasmid and ectopic expres-
sion of the tagged proteins was achieved by copper
induction. Using anti-HA antibody, we were able to
immunoprecipitate N-terminally tagged Ths and Pyr
from the culture medium, demonstrating directly for the
first time that the proteins are indeed secreted (Fig. 2B,
lanes 2 and 3).
Instead of identifying secreted proteins at the pre-
dicted full-length molecular weights, we found the pre-
dominant secreted forms consisted of multiple bands
running at ~35 kD for Ths and ~50 kD for Pyr (Fig. 2B,
lane 2 and 3, respectively), indicating that the cleaved
N-terminus of each protein is secreted.
Cleaved forms of Ths and Pyr are detected in embryonic
extracts
To investigate whether Ths and Pyr proteins are also
cleaved in the animal, we expressed tagged versions of
these proteins (i.e., pUASt-HA-Ths and pUASt-HA-Pyr)
in the embryo using the pan-ectodermal driver 69B-
GAL4. Embryonic extracts were prepared from 1 gram
of collected embryos, age 0-24 hour, and N-terminal
protein species were isolated by using an anti-HA anti-
body for immunoprecipitation. Cleaved forms of both
Ths and Pyr were detected in these samples, at ~35 kD
for Ths and ~45 kD for Pyr (Fig. 2C). The ability to
detect cleavage products from embryonic extracts of
approximately the same size as those secreted in S2
cells suggests our analysis of Ths and Pyr processing in
S2 cells may also be relevant to FGF function in the
Drosophila embryo.
The C-terminal domain of Ths can be secreted, but not
that of Pyr
Our ability to detect cleaved products in the S2 cell cul-
ture system, similar in size to those present in the ani-
mal, gave us confidence that we could use cell culture
to obtain additional insights into these proteins. There-
fore, we also examined the cell pellet fractions and
found that cleaved N-terminal domains of Ths and Pyr
are present inside the cell as well (Fig. 2B, lane 5 and 6).
This result suggests that cleavage occurs inside the cell.
To examine this possibility more closely, we assayed for
the presence of full-length forms of Ths or Pyr inside
and outside the cells.
In the HA-Ths-Myc cell pellet sample, in addition to
the smaller potentially cleaved forms of Ths, we also
detected a polypeptide of 150 kD, one that is much lar-
ger than the predicted size for Ths protein (~80 kD) or
that is observed when the cDNA is translated in vitro
(Fig. 2B, lane 6, compare with Fig. 2A). To confirm that
this protein species represented the full-length form of
Ths, we immunoprecipitated with anti-Myc and blotted
with anti-HA to identify both the C- and N-termini
simultaneously. We observed that both N- and C-ter-
mini were connected in the 150 kD band in both the
supernatant and cell pellet (Fig. 2D). Therefore, the 150
kD band probably represents full-length Ths, likely
modified by glycosylation or other modifications that
retard its mobility when assayed by SDS-PAGE and
Western blot. Collectively, these results are consistent
with the idea that the majority of Ths is cleaved intra-
cellularly and secreted, while some full-length form is
also secreted at lower levels.
Subceullular Localization of Pyr and Ths
We were not able to immunoprecipitate the predicted
full-length Pyramus protein from the cell pellet or
supernatant using a combination of anti-HA and anti-
Myc antibodies, nor could we detect the cleaved C-
terminus of Pyr by Western blot using an anti-Myc
antibody; in contrast, full-length Ths could be detected
in the supernatant at 150 kD even in the absence of
immunoprecipitation (Fig. 2D). Possible interpretations
of these results are that (1) Pyr protein is processed
from full-length very quickly intracellularly, (2) that in
S2 cells Pyr protein is never made as a “full-length”
form, or alternatively, (3) the Myc epitope is not accessi-
ble. To address this question, we stained S2 cells expres-
sing HA-Pyr-Myc constructs with either anti-HA or
anti-Myc antibodies (Fig. 3). The stainings provided sup-
port that the N-terminus of Pyr (marked by the HA-tag)
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is secreted from the cell, as staining at the cell periphery
was observed even in the absence of cell permeabiliza-
tion (Fig. 3A,D). In contrast, the anti-Myc staining sug-
gested that the C-terminus of Pyramus is present solely
within cells, within an unidentified organelle, possibly an
endosome (Fig. 3B). No anti-Myc staining could be
observed for HA-Pyr-Myc in the absence of permeabili-
zation (Fig. 3E). As a control for the accessibility of the
Myc epitope, we used a C-terminally fused Pyr-GFP
construct and anti-GFP antibody to confirm the location
of the Pyr C-terminus. The anti-Myc and anti-GFP
stainings of HA-Pyr-Myc and Pyr-GFP, respectively,
exhibit the same intracellular staining that is lost in the
absence of permeabilization (Fig. 3B,C,E,F). This data
suggests that the C-terminus of Pyramus is translated,
but that the full-length and C-terminus of the protein
stays within the cell and is not secreted. Stainings for
Ths confirmed what was seen in Western blots. The N-
terminus was present both inside the cell (Fig. 3G) and
at the membrane in non-permeabilized cells (Fig. 3J).
Figure 3 Visualization of N- and C-termini in S2 cells shows a difference in the subcellular localization of Ths and Pyr C-terminus. S2
cells were transfected with the indicated pUASt.HA-Pyr-Myc, pUASt.Pyr-GFP, pUASt-Ths-GFP or pUASt.HA-Ths-Myc constructs (see methods), and
immunofluorescence was conducted using anti-HA, anti-Myc, or anti-GFP antibodies (all “red”). HA-Pyr-Myc was stained with anti-HA to see the
N-terminus (A,D) where predominant ER staining was seen inside the cell (A) while only membrane staining was seen under non-permeabilizing
conditions (D). The C-terminus of Pyr was visualized with anti-Myc for HA-Pyr-Myc (B,E) or anti-GFP for Pyr-GFP (C,F). The C-terminus of Pyr inside
the cell was localized to small, non-nuclear vesicles, which may be endosomal in character (B,C). No Pyr C-terminus was visualized outside of the
cell (E,F). Anti-HA was used to visualize the HA-Ths-Myc N-terminus under permeabilizing (G) and non-permeabilizing conditions (J), revealing ER
staining around the nucleus inside the cell (G) and proteins attached to the cell membrane (J). Anti-Myc (H,K) and anti-GFP (I,L) were both used
to visualize the Ths C-terminus of either HA-Ths-Myc or Ths-GFP. Again, ER staining was seen inside the cell (H,I) and membrane staining was
observed under non-permeabilized conditions (K,L).
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Stainings marking the C-terminus of Thisbe with anti-
Myc and anti-GFP support the idea that the C-terminus
Thisbe protein is secreted, although this could represent
either a full-length or cleaved form (Fig. 3H,I,K,L).
Therefore, we propose that there may be a difference in
the number of forms secreted for Ths versus Pyr: Ths
may be secreted as both a full-length and a cleaved
form, whereas Pyr is only secreted as a cleaved form
with the C-terminus being retained intracellularly.
Truncation constructs reveal the FGF domain alone is
sufficient for function
In order to reconcile the biochemical evidence for
cleaved forms with the endogenous function in the
embryo, we made a series of N-terminally, HA-tagged
truncation constructs and used the site-directed trans-
genic method to insert all transgenes in the same geno-
mic location on the third chromosome, 86FB, to
minimize positional effects [47]. We cannot be sure that
the act of truncation itself does not impart differences
in the stabilities of the produced proteins; in fact, stabi-
lity of the proteins (possibly regulated by cleavage
events) may be one mechanism by which their activities
are regulated. However, by minimizing positional effects
on the transgene, we standardized expression levels for
each of the constructs to the best of our abilities.
During stage 10 to 11, FGF signaling through Htl con-
tributes to differentiation of the mesoderm into specific
cell types, including the pericardial cells of the future
heart tube and dorsal somatic muscle [36]. At this stage,
pyr, and to a lesser extent ths as well, is expressed in
the ectoderm overlying the developing heart cells [16].
Signaling through Htl, presumably by wild type endo-
genous levels of Pyr/Ths, supports the generation of
three Eve-positive cells per hemisegment (Fig. 4A and
[48]), while overexpression of either Ths or Pyr leads to
the expansion of this cluster up to 20 cells [18].
We used the expansion of the Eve-positive cell clus-
ter as a functional readout to test the function of Ths
or Pyr tagged, truncated proteins when overexpressed
in the ectoderm with 69B-GAL4. First, addition of HA
and Myc tags to Ths and Pyr did not affect the ability
of Ths and Pyr to cause an expansion of the Eve-posi-
tive cluster (Fig. 4B,F). Furthermore, of three trunca-
tion constructs engineered for Ths, two were
functional (HA-Ths1-158 and HA-Ths1-403) and one was
not (HA-Ths1-261). The two that were functional were
also secreted, as confirmed by expression in S2 cells,
while the construct that was not functional was not
secreted (Fig. 4C,D,E); the non-functional truncation
may disrupt an essential secondary structure required
for proper folding and in turn secretion. Remarkably,
the small HA-Ths1-158 was secreted and functional, yet
this polypeptide contains little more than the FGF
domain alone. Together, these data suggest that the
FGF domain alone is sufficient for function of Ths and
that secretion is also required for function.
Three truncated constructs were engineered for Pyr as
well: Pyr1-220, Pyr1-348, and Pyr1-466. Similar to the
results from Ths, the two Pyr truncations that were
secreted were also functional (Pyr1-348 and Pyr1-466) (Fig.
4H,I), while Pyr1-220 was neither secreted nor functional
(Fig. 4G). Unlike Ths, the fact that Pyr1-220 was not
functional suggests that the shortest functional Pyr con-
struct requires additional sequence besides the FGF
domain. It may be possible to make a shorter functional
construct of Pyr; the Pyr1-220 construct may have been
terminated in a location critical for proper folding.
Nevertheless, the functionality of Pyr1-348 suggests aa
residues 349-766 are not required for activity.
Differential range-of-action resulting from limiting the
source of FGF
Previous studies on the function of Ths and Pyr have
speculated that a possible difference in their signaling
capacity is due to either a differential range-of-action
of the ligands diffusing from their source of expression
or due to an unequal potency of activating the recep-
tor (e.g., receptor-binding affinity) [18]. In order to
address these unanswered questions and to gain more
sensitivity than was possible with the pan-ectodermal
69B-GAL4 Eve-positive cluster assay (Fig. 4), we used
a different driver, ZenKr-GAL4 which drives expres-
sion in a subset of the embryonic dorsal ectoderm
starting just before stage 9; at this stage embryos have
undergone 50% of germ band elongation and expres-
sion supported by the driver is localized to the poster-
ior (Fig. 5G’ and zen.VRE.Kr-GAL4 [40]). For each
construct, the number of Eve-positive cells per cluster
in each hemisegment of 25 embryos was counted,
averaged and compared. The clusters were tracked
within embryo hemisegments as indicated by the num-
bers on Fig. 5A. ZenKr-Gal4 supports expression in
clusters 4-7 (as seen in inset Fig. 5G’) and this domain
is represented on the graphs by a shaded gray box in
the background.
ZenKr-GAL4 driving full length HA-Ths-Myc and
HA-Pyr-Myc both resulted in extra Eve-positive cells
outside the expression domain supported by the ZenKr
enhancer (i.e., clusters 1-3 and 8-11) (Fig. 5A,D).
Furthermore, expression of HA-Pyr-Myc resulted in
more Eve-positive cells within every hemisegment as
compared with expression of HA-Ths-Myc (Fig. 5G).
One interpretation of this result is that Pyr may be
more potent in its activation of the Htl receptor and
another is that the Pyr protein is secreted at higher
levels or is more stable than Ths. Both HA-Pyr-Myc
and HA-Ths-Myc supported more Eve-positive cells at
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the source (i.e., clusters 4-7; gray box) and tapered off in
a graded manner to more distant clusters (Fig. 5G).
Expressing HA-Ths1-158 in the ZenKr domain resulted
in a surprising result: when compared to full length
HA-Ths-Myc, HA-Ths1-158 supported the expression of
many more Eve-positive cells in each hemisegment,
even those farthest from the source (Fig. 5B,H, especially
clusters 1 and 11). Compared to full-length HA-Ths-
Myc, HA-Ths1-158 also had a dramatically different pro-
file of Eve-positive cell numbers; instead of peaking at
the source and dropping off in a graded manner, there
was close to maximum expression of Eve supported in
almost every hemisegment (Fig. 5H). In contrast, the
other truncated Ths construct, HA-Ths1-403 showed an
increase of Eve positive cells as compared to HA-Ths-
Myc within clusters at the source yet tapered off in
activity in more distant clusters, a profile similar to that
of the full length construct (Fig. 5C,H). In summary,
two changes in trend were associated with constructs
HA-Ths1-158 and HA-Ths1-403 compared with full-length
Ths: (I) flattened profile versus (II) increase peak yet
graded profile, respectively.
With the overexpression of the ligands limited to the
domain of ZenKr-Gal4 expression, we favor the idea
that supernumerary Eve-positive cells in hemisegments
outside this domain would most likely result from an
Figure 4 Ths and Pyr truncation constructs that support the production of secreted proteins in cell culture are also functional in the
embryo. (A) Stage 11, wild type embryos, lateral view, stained with anti-Eve antibody show Eve-positive staining in three cells per hemisegment.
The enlargement of the Eve-positive area is 1.8x. (B-I) pUASt-HA-Ths and pUASt-HA-Pyr full-length and truncated construct schematics; assay for
secretion was conducted in S2 cell culture. Embryos overexpressing indicated constructs with 69B-GAL4 were stained with anti-Eve antibody to
score for FGF activity. (B) Overexpression of full-length Ths results in more Eve-positive cells (Eve+++). (C, E) HA-Ths1-158 and HA-Ths1-403 are both
secreted and Eve +++, but (D) HA-Ths1-261 is not secreted and does not support more Eve-positive cells. (F) Overexpression of full length Pyr
also results in Eve+++. (G) HA-Pyr1-220 is not secreted and does not give more Eve-positive cells, but (H, I) HA-Pyr1-348 and HA-Pyr1-466 are both
secreted and exhibit the Eve+++ phenotype.
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Figure 5 Restricting the source of full-length and truncated Ths and Pyr constructs reveals a functional difference . (A-F)
Immunohistochemistry on stage 11 embryos, lateral view, all constructs driven with ZenKr-GAL4; embryos were stained using an anti-Eve
antibody. (A) White numbers indicate position of numbered Eve-positive clusters; ZenKr-GAL4 supports expression in clusters 4-7. (A-F) Eve
staining reveals additional Eve-positive cells outside the ZenKr domain for (A) HA-Ths-Myc (B) HA-Ths1-158 (C) HA-Ths1-403 (D) HA-Pyr-Myc (E) HA-
Pyr1-348 (F) HA-Pyr1-466. (G,H,I) Eve-positive cells per cluster were counted in each hemisegment for 25 embryos per construct tested and
averaged. Error bars indicate standard error. (G) The hatched line at “3” represents the wild-type level of Eve-positive cells. The gray box
represents the source of expression supported by ZenKr-GAL4. Plot of Eve-positive cells generated by ZenKr-GAL4 ® pUASt-HA-Ths-Myc as
compared to ZenKr-GAL4 ® pUASt-HA-Pyr-Myc shows that Pyr has greater functional activity than Ths. Ths and Pyr both give a graded output
of Eve-positive cells with the most cells in the source domain. (G’) ZenKr-GAL4 driving UAS-lacZ and stained with anti-bgal shows the domain of
the driver in the posterior dorsal ectoderm of the embryo. (H) ZenKr-GAL4 ® pUASt-HA-Ths1-158 does not have the same Eve-positive profile,
instead it results in more Eve-positive cells in clusters 8-11. ZenKr-GAL4 ® pUASt-HA-Ths1-403 has increased activity locally but similar levels of
function to HA-Ths-Myc at long-range (I) ZenKr-GAL4 ® pUASt-HA-Pyr1-348 and ZenKr-GAL4 ® pUASt-HA-Pyr1-466 both retain a graded profile of
Eve-positive cells, although HA-Pyr1-348 supports more Eve-positive cells in distant clusters 8-11 as compared to HA.-Pyr1-466.
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increase in diffusion of the ligands from their source of
ectopic expression or decreased receptor-mediated endo-
cytosis; however we cannot dismiss an alternate scenario
in which this result is supported by the Ths1-158 protein
being more stable than other constructs. In either case,
our results suggest the C-terminus of Ths has an inhibi-
tory function (for example, either affecting stability,
endocytosis or diffusion) and possibly that cleavage of
Ths plays a regulatory role in increasing the ability of this
protein to support activation of FGFR.
We also expressed both functional truncations of Pyr
with ZenKr-GAL4 and found that overexpression of
both HA-Pyr1-348 and HA-Pyr1-466 supported additional
Eve-positive cells (Fig. 5E,F). For both HA-Pyr1-348 and
HA-Pyr1-466 the profile was similar to trend II seen for
HA-Ths1-403 : increased peak levels but graded profile
(Fig. 5I). Our hypothesis is that only the N-terminal Pyr
cleavage product is secreted and the C-terminus remains
intracellular so truncated Pyr would be expected to sup-
port a similar response to expression of full-length Pyr
due to essentially the same net protein fragment being
secreted. We do indeed see a similar profile of expres-
sion (i.e., graded profiles). However, the outputs
observed for the two Pyr truncation constructs and full-
length Pyr are not identical; we suggest these differences
may be due to differences in protein production (e.g.,
stability, differential processing inside the cell, and/or
rate of secretion).
Pyr truncation constructs are modified
In S2 cell supernatants, truncated Pyr constructs, HA-
Pyr1-348 and HA-Pyr1-466 run at the same size on Western
blots despite the larger construct containing 118 more
amino acids (Fig. 6A). To understand if this was due to
post-translational modifications we expressed both trun-
cated constructs in a cell-free transcription/translation
system and compared them to the size of the bands
immunoprecipitated with anti-HA from the S2 cell
supernatant. In S2 cells, HA-Ths1-158 and HA-Pyr1-466
ran similar to their predicted sizes (20 kD and 50 kD,
respectively) but HA-Pyr1-348 ran larger than its predicted
size (at 50 kD instead of 35 kD), indicating that it may be
glycosylated or otherwise modified (Fig. 6A). These mod-
ifications could correspond to the predicted O-glycosyla-
tion sites between aa 177 and 201 in Pyr (Fig. 1). When
HA-Pyr1-348 was expressed in the cell-free system (with-
out the opportunity for post-translational modifications
including glycosylation), it ran at its predicted size of 35
kD (Fig. 6B). HA-Pyr1-466 likely contains the same modi-
fications (and would likely also run larger than predicted,
possibly around 65 kD), but we hypothesize it is subse-
quently cleaved to the smaller 49/50 kD size of secreted
Pyr (Fig. 6C, predicted sequential steps 1-3). Carbohy-
drate modifications such as glycosylation can significantly
affect the secretion, diffusion and binding capabilities of
ligand proteins and the difference in modifications
between Ths versus Pyr could contribute to their indivi-
dual capabilities.
Ths-Pyr chimeras reveal differences between Ths and Pyr
C-termini
Results from the truncation constructs showed that
eliminating the C-terminus from Ths has a different
effect than eliminating the C-terminus from Pyr (see
Figure 6 Post-translational modifications contribute to the observed molecular weight of Pyramus. (A) Supernatants from S2 cultured
cells, immunoprecipitated with anti-HA, blotted with anti-HA. HA-Ths1-158 runs at the expected size of 20 kD, but HA-Pyr1-348 runs larger than
predicted, at the same size as HA-Pyr1-466. (B) In vitro transcription/translation of HA-Pyr1-348 (left lane) and HA-Pyr1-466 (right lane) blotted with
anti-HA, show HA-Pyr1-348 is likely post-translationally modified in vivo. (C) Schematic showing predicted events to explain the results in A and B:
1.) HA-Pyr1-348 and HA-Pyr1-466 are both translated to their predicted sizes as seen in vitro in (B). 2.) HA-Pyr1-348 and HA-Pyr1-466 are both modified
post-translationally, likely by the addition of carbohydrate chains which increase their molecular weight to 50 kD and >50 kD (unobserved). 3.)
HA-Pyr1-466 is probably subsequently cleaved to decrease its molecular weight to 50 kD. Small branching trees represent modifications and the
inverse triangle represents a predicted cleavage site.
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Fig. 5H,I). To further address the differences in the N-
and C-termini of Ths and Pyr, we made chimeric pro-
teins containing the N-terminus from one ligand and
the C-terminus from the other, ThsN-PyrC and PyrN-
ThsC. Both chimeras were secreted and functional, giv-
ing extra Eve-positive cells when driven by 69B-GAL4
(Fig. 7A). In S2 cell culture, both chimeras were pro-
cessed and secreted as cleaved forms. When the N-ter-
minus of each chimera is detected using an anti-HA
antibody, we find that ThsN-PyrC is cleaved into a 50/
52 kD doublet, and one band at 30 kD (Fig. 7B lane 4);
as a result, it may contain cleavage sites and/or modifi-
cations derived from both Pyr and Ths. PyrN-ThsC is
present as a small doublet around 30/35 kD, indicating
it is likely cleaved and modified according to informa-
tion derived from its Ths sequence (Fig. 7B lane 3
compared with lane 2). Importantly, this result shows
that the cleavage is dependent upon the specific Ths or
Pyr ligand sequence used and swapping sequence out-
side the FGF-domain allows us to see how the FGF-
domain of one ligand acts in the context of processing
like the other ligand.
The chimeras were also driven by ZenKr-GAL4 and the
Eve-positive cells counted as was previously done for the
truncated constructs. ThsN-PyrC supported more Eve-
positive cells than HA-Ths and furthermore had the
same altered profile as HA-Ths1-158 (Fig. 7C,E). PyrN-
ThsC had decreased Eve-positive cell clusters compared
to the HA-Pyr1-348, and was similar to full-length Pyr
(Fig. 7D,F). These results demonstrate that the Pyr C-ter-
minus does not have the same inhibitory effect on the
Ths N-terminus that the Ths C-terminus does.
Figure 7 Ths-Pyr Chimeras highlight inhibitory activity of Ths C-terminus. (A) Schematics of ThsN-PyrC and PyrN-ThsC chimeric constructs
and stage 11 embryos with 69B-GAL4 driving expression and function monitored with anti-Eve. Both chimeras give the +++Eve phenotype,
meaning they support FGF activity. (B) Both chimeras are secreted, but cleaved differently in S2 cells. Supernatant immunoprecipitated with anti-
HA and blotted with anti-HA, shows PyrN-ThsC is cleaved in a manner similar to Ths, while ThsN-PyrC may have both Pyr and Ths-derived
cleavage sites. (C,D) Anti-Eve in stage 11 embryos with each chimera driven by ZenKr-GAL4 shows +++Eve cells in clusters outside the ZenKr
domain for (C) pUASt-ThsN-PyrC and (D) pUASt-PyrN-ThsC. (E,F) Comparisons of Eve-positive cells per cluster in each hemisegment, scored and
averaged as in Fig. 5. (E) ZenKr-GAL4 ® ThsN-PyrC gives more Eve-positive cells than HA-Ths-Myc, suggesting that the Pyr C-terminus does not
inhibit the Ths N-terminus the way that the Ths C-terminus does. (F) ZenKr-GAL4 ® PyrN-ThsC has fewer Eve-cells than ZenKr-GAL4 ® HA-Pyr1-
348, and is similar to full-length HA-Pyr-Myc indicating the Ths C-terminus can likewise inhibit the Pyr N-terminus.
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Deleting putative cleavage region renders Ths non-
cleavable
In order to address whether the Ths cleavage is neces-
sary for proper function, we attempted to engineer a
Ths construct with a deletion of the putative cleavage
sites to create an un-cleavable form of the ligand. To
determine which region to delete, we considered the
size of the 30-35 kD bands secreted in S2 cells and diba-
sic/multibasic Arginine/Lysine sequences characteristic
of the recognition sites of furin-like proteases responsi-
ble for processing proproteins of other growth factors
like Dpp into mature forms [43]. Sequences underlined
with a red line (Fig. 8A) contain basic amino acids
stretches of [R/K]-[Xn]-[R/K] where × indicates any
amino acid residue and n is 0, 2, 4, or 6, which is the
consensus recognition sequence for furin-related pro-
protein convertases [43].
We deleted a 72 aa region containing 5 putative clea-
vage sites to generate the construct HA-ThsΔ261-333 -Myc
(Fig. 8A). When HA-ThsΔ261-333-Myc was immunopreci-
pitated from S2 cell culture with anti-HA antibody, the
full-length band became much more prominent than that
associated with HA-Ths-Myc (Fig. 8B, lane 3 vs. 2),
although cleavage products still remain. We then
extended the deleted region 23 aa further to remove one
additional weak match to the furin consensus sequence
to make HA-ThsΔ261-356-Myc. The cleaved bands were
further diminished, although one band of ~35 kD was
still detectable (Fig. 8A and 8B, lane 4). The simplest
interpretation is that these 95 amino acids include most
of the relevant cleavage sites for Ths, and deleting them
results in a shift of the dominant Ths protein species to
the full-length form.
The function of HA-ThsΔ261-356-Myc was tested using
both the 69B-GAL4 assay and the ZenKr-GAL4 assay.
We hypothesized that the drastic reduction of cleaved
Ths and the presence of increased full-length Ths would
result in either dramatically less function if cleavage
were activating or dramatically more function if cleavage
were inactivating. Surprisingly, the result was neither of
these extremes, but instead HA-ThsΔ261-356-Myc was
still able to generate supernumerary Eve positive cell
Figure 8 Cleavage of Ths can be prevented through deletion of internal amino acids. (A) Thisbe amino acid sequence deleted in ThsΔ261-
333Myc, including 5 potential cleavage sites, underlined in red; below the dotted black line are the amino acids that differ between the two
deletion constructs, ThsΔ261-333Myc and ThsΔ261-356Myc, including 1 additional potential cleavage site, underlined in red. (B) Western blot of anti-
HA immunoprecipitations from supernatant of cells transfected with pUASt-empty, HA-Ths-Myc, HA-ThsΔ261-333Myc, and HA-ThsΔ261-356Myc. HA-
Ths-Myc was loaded 5x less than the other samples to equalize the exposure while resolving the double-band at 35 kD. ThsΔ261-333Myc (lane 3)
is still partially cleaved but has increased full-length protein and (lane 4) ThsΔ261-356Myc has less cleavage and more full-length product, as
compared to HA-Ths-Myc (lane 2). (C) 69B-GAL4 driving ThsΔ261-356Myc results in more Eve-positive cells in every hemisegment, as compared to
wild-type. (D) ZenKr GAL4 driving ThsΔ261-356Myc results in extra Eve-positive cells outside the source of expression. (E) Eve-positive cells counted
in 11 hemisegments for 25 embryos and averaged as in Fig. 5. The gray box represents the source of expression supported by ZenKr-GAL4. As
compared to HA-Ths-Myc, ThsΔ261-356Myc has a decreased gradient of functional output, resulting in a flatter profile.
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clusters like the other constructs (Fig. 8C) and when the
source of expression was limited using ZenKr-GAL4,
the graded output of Eve positive cells was flattened as
compared to HA-Ths-Myc (Fig. 8D, E), similar to the
profile of HA-Ths1-158, yet not as potent an activator
(compare with Fig. 5H).
Thus by deleting 95 aa, we can affect the proteolytic
processing of the Ths protein such that the majority of
the protein is present as full-length. Because this con-
struct supports detectable activity, we suggest it is
unlikely that cleavage is required for this activity.
However, we cannot dismiss this possibility as some
cleaved product is detected and the effective dose of
FGFs is often very small; the remaining cleaved pro-
ducts in HA-ThsΔ261-356-Myc may be sufficient to
function when overexpressed at high levels with GAL4
drivers. Nevertheless, HA-ThsΔ261-356-Myc supports an
expanded profile similar to HA-Ths1-158; perhaps the
flattened output is an indication that both of these
proteins are not endocytosed properly (see Discussion).
It is possible that cleavage is required before ligands
can be effectively endocytosed from the extracellular
space.
Discussion
Proteolytic processing regulates many signaling mole-
cules in both vertebrates and invertebrates, and unlock-
ing the mechanisms behind regulatory cleavage events
has been an on-going effort for each protein. In 1990,
Dpp was first reported to be cleaved in S2 cells [45],
and recent studies have continued to piece together the
details of the maturation of the Dpp protein [28]. Our
current analysis is the first evidence for cleavage of Ths
and Pyr FGF ligands for the Htl FGFR. In this study we
have shown that Ths and Pyr proteins are both cleaved
and secreted from S2 cells and cleaved Ths and Pyr can
be detected in embryonic extracts. Truncated ligands
with the N-terminal FGF-domain are functional. Addi-
tionally, spatially restricting the source of FGF ligands
and using domain-swapped chimeras revealed that the
C-terminus of Ths has an inhibitory capability while the
C-terminus of Pyr does not.
The roles of Ths and Pyr C-terminal domains are different
The C-terminus of Ths, but not that of Pyr, can be
detected extracellularly in tissue culture cells, suggesting
that the processing situation for Ths is likely different to
that for Pyr and raising the possibility that the function
of the C-termini of these proteins has diverged. Even
though we can detect cleaved forms of Ths inside the
cell, indicating that cleavage likely occurs intracellularly,
we can also detect both full-length and cleaved forms of
Ths outside of the cell. Why would both forms be
secreted if only the cleaved form was necessary to
participate in receptor binding? In the case of Notch,
two of the processed forms remain non-covalently asso-
ciated and must be further processed for release [32]. In
the case of Ths, the presence of both the unprocessed
form and the processed form outside the cell creates the
opportunity for an interaction.
While expression of full-length Ths has a graded
range-of-action, we were surprised to find that truncated
Ths has an extended range-of-action which suggests that
the C-terminal domain is inhibitory. The mechanism by
which the C-terminus of Ths accomplishes its inhibitory
role remains an intriguing question. Does the C-termi-
nus affect the rate of cleavage, the diffusion range, the
rate of endocytosis, or might it physically interact with
the N-terminus to directly inhibit FGF binding to the
receptor? The Ths C-terminus has a similar effect on
the Pyr FGF domain-containing N-terminus, as the
PyrN-ThsC chimera is functionally restricted compared
to the shorter Pyr1-348. In contrast, the Pyr C-terminus
does not have the same effect on the Ths N-terminus,
as ThsN-PyrC is highly potent and diffuses in an unrest-
ricted manner, similar to truncated Ths1-158.
Our data supports the view that Pyr is processed
inside the cell and that only the N-terminal cleaved
form is released; therefore the Pyr C-terminus may only
have a cell autonomous effect and likely does not affect
the secreted protein directly once it is released. The
local potency of HA-Pyr-Myc is less than the truncated
Pyr constructs; so we propose cleavage of Pyr inside the
cell may be a rate-limiting step.
Our results are also consistent with the idea that
Pyramus could contain a transmembrane domain, as
predicted, although our inability to follow the Pyr C-
terminus has prevented us from confirming this pre-
diction. Although we have not yet uncovered a specific
role for the Pyr C-terminus, of note is the fact that the
C-terminal domain of Pyr exhibits homology to the
intracellular protein human protein Trinucleotide
Repeat-Containing 15 (Tnrc15) implicated in Parkin-
son’s disease (18% identity vs. 38% similarity over an
approximately 500 aa stretch; data not shown) [49].
Tnrc15 interacts with Grb10, which, in turn, interacts
with EGFR, MAP2K1 and many other signaling mole-
cules [50]. This homology suggests the Pyr C-terminus
may function inside the cell to regulate signaling, a
function that likely is distinct from that of the Ths C-
terminal domain.
Processing of FGF ligands: proteolytic cleavage and post-
translational modification
Further studies will be required to understand the role
that processing of Ths and Pyr plays in the regulation of
FGF signaling in Drosophila. The proteases responsible
for the processing may themselves be spatially or
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temporally regulated at the transcriptional level, or sepa-
rated into different subcellular compartments. Addi-
tional regulation of FGF signaling activity by proteases,
which alter ligand activity and/or diffusion, could
explain how FGFs are able to perform so many distinct
functions in animals. For example, the diffusion range of
Ths and Pyr, possibly regulated by proteolytic cleavage,
could be important to support different functions. For
instance, recently we have learned that during gastrula-
tion Ths and Pyr guide the symmetric collapse of the
mesoderm first and subsequently control intercalation
of cells required for monolayer formation [51]. For col-
lapse, a long-range signal might be required, whereas to
support the small cell movements of intercalation a
short-range signal may be more effective. In addition,
findings from the TGF-b signaling family show in some
cases ligands are differentially processed in a tissue-spe-
cific manner. Differential processing of BMP-4 by furin
proprotein convertases results in multiple ligand forms
that exhibit differences in stability and ability to act at a
distance in Xenopus assays [52,53]. Recent results on the
BMP-2/4 homolog, Dpp, have found not only is Dpp
processed in a tissue-dependent manner but different
cleavage products are also required to provide sufficient
function for wing and leg versus gut development
[28,54]. These examples highlight the importance of
ligand processing as a key mechanism used by the cell
to control ligand presentation and tissue-specific
signaling.
Range of action: diffusion and regulated endocytosis
Diffusion range is very important for most secreted sig-
naling molecules, and this range may be influenced by
post-translational modifications, proteolysis, or interac-
tions with other secreted molecules. Recent work from
zebrafish has shown that the common homolog of Ths
and Pyr, FGF8, can act as a morphogen and spread
from its source in the mid-hindbrain boundary by sim-
ple diffusion[55]. A slower-moving species of FGF8 was
also detected, which is thought to be interacting with
heparin sulfate proteoglycans (HSPGs) in the extracellu-
lar matrix. HSPGs are extracellular matrix and cell sur-
face macromolecules that consist of a protein core to
which heparin sulfate (HS) glycosaminoglycan (GAG)
chains are attached. HSPGs are required as a co-recep-
tor in vertebrate FGF signaling and might also be
involved in Drosophila FGF signaling [56]. Alternatively,
the excessive glycosylation implicated in the molecular
weight of full-length Ths (150 kD compared to the pre-
dicted size of 82 kD) implies that the fully modified Ths
molecule may likely be slow diffusing even without
binding to HSPGs. Cleaved Ths might be freed from
such glycosylation-mediated “inhibition” and allowed to
diffuse farther and faster. The full-length and fully
modified form may be protected from proteolysis by gly-
cosylation [57], resulting in local FGF signaling, which
may be preferred in some cases. Future studies will
explore whether Ths and Pyr have different diffusion
rates, and if these rates are affected by post-translational
modification.
Furthermore, the gradient formed by the HA-Ths-Myc
construct may be dependent on the uptake of ligand in
a “source-sink” mechanism similar to what is observed
for FGF8 diffusion in the zebrafish developing midbrain-
hindbrain region [55]. In this scenario, cleavage could
produce a form of Ths that is recognized and endocy-
tosed, and may explain the more long-range activity
associated with HA-ThsΔ261-356-Myc. Along these lines,
short Ths1-158 may be lacking such an internalization
sequence to support the “flattened” output profile
observed.
In the embryo, the switch between secretion of trun-
cated or full-length ligand could be tissue-specific or
temporally regulated as a means to support differential
activity/range of the ligands. Once the proteases that
process Ths and Pyr are uncovered, it will be possible to
study the relationship between proteolysis and range-of-
action.
Implications for vertebrate studies
Lastly, this new molecular data on Ths and Pyr raise
questions about the evolutionary history of the FGF
family. All 24 FGF family members in vertebrates are
relatively small proteins. Did Ths derive its long C-ter-
minus in the Drosophila lineage indpendently before it
was duplicated to produce Pyr, or was the ancestral FGF
a long protein with cleavage sites that were lost in the
vertebrate lineage? To obtain some insight into these
questions, we can look to FGFs characterized in other
animal models [58]. Worms have two FGF ligands, LET-
756 and EGL-15. EGL-17 is small and LET-756 is 425
aa, an intermediate size, but not known to be cleaved
[59,60]. Additionally, Bnl, the other FGF ligand in Dro-
sophila, is approximately the same size as Ths and Pyr
(i.e., 84 kD), although it is not more related to them
than Ths/Pyr are to FGF8 [61]. Therefore, it seems most
likely that the Drosophila genome tolerates the length-
ening of proteins and has found secondary ways of pro-
cessing them during post-translational regulation. This
theory of differential genome tolerance was also put
forth by Schmid and Tautz regarding Drosophila tran-
scription factors, which are on average 30% longer than
their Tribolium homologs [62]. Another possibility
(which is not mutually exclusive) is that the Drosophila
FGF ligands are multi-functional proteins, with the
FGF-homologous portions responsible for activation of
FGFRs and with the low-complexity regions (i.e., C-ter-
mini for Pyr and Ths) supporting additional functions,
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other than receptor-binding, required to support FGF
signaling. Furthermore, while Ths and Pyr likely arose
from an ancient duplication, [16], the C-termini of these
proteins have diverged: the Pyr C-terminus is most simi-
lar to an intracellular protein (i.e., Tncr15 which inter-
acts with the adaptor Grb10) and the Ths C-terminus
exhibits homology to highly glycosylated proteins, likely
found extracellularly. In vertebrates, studies on the
Klotho protein suggest that at least some endocrine
FGFs interact with additional proteins to influence
receptor binding and activity [63]. Perhaps the Droso-
phila FGFs are ancestral multi-functional ligands that
combine ligand-binding and Klotho-like adaptor or
HSPG functions. In any case, whether these “long” FGFs
are novel inventions of Drosophilids or ancient remnants
of more ancestral FGFs, we contend that the modular
nature of Drosophila FGFs may provide important
insights into mechanisms that affect FGF activity, which
is best examined by comparing the activities of the
diverged ligands, Ths and Pyr.
Conclusions
In the present study we have provided evidence for the
proteolytic processing of Drosophila FGF ligands Ths
and Pyr in both S2 cell culture and the embryo. Func-
tional data was presented showing that truncated, FGF-
domain-containing N-termini are capable of functioning
in the embryo without their respective C-termini.
Restricted ectopic expression in vivo demonstrated the
difference in signaling capability between Ths and Pyr
in embryos and domain-swapped chimeras highlighted
the differences in the C-terminal domains of Ths and
Pyr. These findings advance our understanding of the
mechanism of FGF signaling in Drosophila and also sug-
gest FGF signalling in Drosophila may be even more
similar to that in vertebrates.
Methods
Prediction Programs
N-glycosylation sites in the Drosophila FGFs were pre-
dicted using the NetNGlyc Server version 1.0 at http://
www.cbs.dtu.dk/services/NetNGlyc/[64]. O-glycosylation
sites were predicted using OGPET version 1.0 prediction
tool, © University of Texas at El Paso (UTEP) El Paso,
TX accessed at http://ogpet.utep.edu/OGPET/contact.
php.
Fly Stocks and Constructs
69B-GAL4 (Brand and Perrimon, 1993) and zenVRE.Kr-
GAL4 (Frasch, 1995) fly stocks have be previously
described. All Ths and Pyr truncation, deletion and chi-
mera constructs were inserted into the pUASt-attB vec-
tor. 1X HA tags were inserted by fusion PCR just after
the N-terminal signal peptide, between amino acid 22
and 23 for Ths (i.e., ALCTV - HAtag - EDYVI) and
between amino acid 30 and 31 for Pyr (i.e., ASAAK -
HAtag - NVLTL). 6X Myc tags were inserted with Xho1
sites at the C-terminus just before the stop codon. HA-
Ths(1-158), HA-Ths(1-261), HA-Ths(1-403), HA-Pyr(1-220),
HA-Pyr(1-348), HA-Pyr(1-466) were all PCR amplified from
full length ths or pyr template and cloned into pUASt-
attB with Not1/Kpn1 sites (Ths constructs) or BglII/Xba
(Pyr constructs) sites. Of note is the fact that a full-
length pyramus cDNA has not been isolated to date,
neither from cDNA libraries nor when primers are uti-
lized to PCR amplify the predicted full-length gene from
cDNA directly. Therefore, the pyr coding sequence in
hand is a recombinant DNA molecule composed of 1
kB of cDNA sequence fused to ~1.3 kB of genomic
sequence, based on the current genome prediction [18].
S2 cell culture and transient transfection
Schneider cells (S2) obtained from the Drosophila
Genomics Resource Center (DGRC) were maintained in
a 25°C incubator in Schneider’s Drosophila Medium
(Invitrogen, #11720-067), supplemented with 10% Fetal
Bovine Serum (USA Scientific, #9871-5200), Pencillin-
streptamycin (dil 1:100), and Fungizone (Invitrogen,
#15290018), and filter sterilized. Cells were passed with
a 1:10 dilution every 4-5 days.
Effectene transfection reagent (Qiagen, #301425) was
used to transiently transfect DNA into S2 cells. 10 ul
Effectene reagent and 3.4 ul Enhancer were used with
1ug DNA in 100 ul EC Buffer. Cells were seeded into 6-
well culture dishes at a concentration of 2 × 106 cells/
well. 100 uM CuSO4 was added the day after transfec-
tion to induce the expression of the vectors from the
metallothionine promoter. Supernatant and cell pellet
fractions were harvested 2 days post transfection. Cells
were lysed with a denaturing lysis buffer (1% SDS, 50
mM Tris, 5 mM EDTA, DTT, DNase and protease inhi-
bitor cocktail). Complete Protease Inhibitor Cocktail
(Roche) was added to the supernatant fractions.
Immunoprecipitation and Western Blotting
Avidin-conjugated beads from Pierce were used to pull
down HA and Myc tagged FGF constructs with a HA-
biotin or Myc-biotin antibody. 250 ul of supernatant or
cell pellet was combined with 50 ul of avidin agarose
beads (Pierce #20219), 25 ul 10x RIPA buffer (500 mM
Tris pH8, 1.5 M NaCl, 5% DOC, 1% SDS, 1-% NP-40,
10 mM DTT, 10X Roche Complete protease inhibitors,
pH to 8.0) and 0.5 ug anti-HA-Biotin (rat, 3F10, Roche
#12158167001) or .01 ug anti-c-Myc biotin conjugated
antibody (mouse, 9E10, Sigma # B7554) and rocked
overnight at 4°C. Beads were washed 3 times 5mins with
1X RIPA buffer, and proteins were released from the
beads by boiling in 1x SDS sample buffer for 5mins.
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Immunoprecipitation samples were run on 10% SDS-
PAGE gels, transferred for 6mins with iblot (Invitrogen)
and blocked for 1 hour at room temperature in 4% milk
in TBS-T. Primary antibodies were used at the following
dilutions: 1:1,000 anti-HA (mouse monoclonal, Covance,
16B12) or 1:10,000 anti-Myc (rabbit, AbCam 9106) 1
hour at room temperature. Blots were then washed 3
times 15mins in 1X TBS-T. Secondary antibodies conju-
gated to HRP were anti-mouse (Upstate, 1 hr. RT,
1:10,000) and anti-rabbit (Biorad, 20mins, 1:10,000).
Blots were washed again 3 times 15mins in 1X TBS-T,
and once for 5mins in H2O to remove Tween. Visuali-
zer (Upstate) was used to develop the blots.
Generating Site-Directed Transgenics and UAS-GAL4
mediated expression
Ths and Pyr constructs were cloned into the pUASt-attB
vector[47]. Proper folding/secretion was assayed in S2
cell culture and by Western Blot before injection. Con-
structs were injected by site-directed transgenesis into
the 86FB location on the third chromosome [47]; Rain-
bow Transgenics (Newbury Park, CA) performed most
injections, some were done in-house.
Immunostaining S2 cells
No. 1 1/2, 22 mm × 22 mm glass coverslips (Corning,
#2870-22) were cleaned by soaking in HCl for 1hr. and
rinsed thoroughly with dH2O. The coverslips were air
dried and treated with 50 uL of 1 mg/mL concanavalin
A (MP Biomedicals, #195283). Transiently transfected
S2 cells were allowed to spread on the coverslips and
attach to the ConA coating. The cells were fixed in 4%
paraformaldehyde for 15mins, rinsed 3X with PBT (1X
PBS + 1% Triton), and blocked in 5% Normal Goat
Serum (Invitrogen) for 10mins. Primary antibodies were
added in 5% block for 1 hr at RT, and then rinsed off.
Antibodies used were: rabbit anti-GFP (1:1000, Invitro-
gen, #A111-22), mouse anti-HA (1:1000, Covance
#16B12) and rabbit anti-Myc (1:10,000, AbCam #9106).
Secondary antibodies (anti-rabbit 555, 1:500, Alexa
Fluor, Invitrogen) were also added in 5% block for 1 hr
at RT and rinsed off. Triton was rinsed off with two
washes in H2O. Samples were mounted to slides with
Vectashield Hardmount.
Immunostaining Drosophila Embryos
3-6 hr embryos were collected and dechorinated in 50%
Bleach for 3mins. The embryos were fixed in Heptane
Fixing Solution [0.4 mL formaldehyde, 4 ml Heptane,
3.6 mL Fixing Buffer (10 mM KPO4, pH6.8, 15 mM
NaCl, 45 mM KCl, 2 mM MgCl2)] for 12mins on an
orbital shaker on high. The Heptane/Formaldehyde was
removed and replaced with MeOH. The embryos were
rinsed in MeOH 4 times and stored at -20°C for short
term or -80°C for long term. Embryos were blocked in
1x western blocking reagent (Roche) for 30mins RT,
and primary antibody incubations were performed over-
night. Primary antibodies used were: anti-Even skipped
rabbit (1:1000, M. Frasch) and anti-bgal rabbit (1:250,
Molecular Probes). Secondary antibody was applied for
1-2 hrs. at RT: anti-rabbit 1:200 (Vectastain, Vector
labs).
In vitro transcription/translation
TnT T7/T3 Coupled Reticulocyte Lysate System (Pro-
mega, #L5010) was used with pBS-Pyr and pBS-Ths,
incorporating S35 Methionine, to assay the unmodified,
full-length size of the proteins. Transcend™ Non-radio-
active Translation Detection System (Promega,
#L5070) containing biotinylated lysine in the Trans-
cend tRNA was used in conjunction with the TnT
Coupled Reticulocyte kit to transcribe and translate
pUASt-HA-Pyr(1-348) and pUASt-HA-Pyr(1-466), which
were subsequently run on 10% SDS-PAGE and
detected with anti-HA by Western Blot.
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